Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Impact of post prostate biopsy hemorrhage on multiparametric magnetic resonance imaging.

Sharif-Afshar AR, Feng T, Koopman S, Nguyen C, Li Q, Shkolyar E, Saouaf R, Kim HL.

Can J Urol. 2015 Apr;22(2):7698-702.

PMID:
25891332
2.

Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.

O'Malley RL, Hayn MH, Brewer KA, Underwood W 3rd, Hellenthal NJ, Kim HL, Sorokin I, Schwaab T.

World J Urol. 2015 Mar 25. [Epub ahead of print]

PMID:
25805189
3.

Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma.

Lane BR, Derweesh IH, Kim HL, O'Malley R, Klink J, Ercole CE, Palazzi KL, Thomas AA, Rini BI, Campbell SC.

Urol Oncol. 2015 Mar;33(3):112.e15-21. doi: 10.1016/j.urolonc.2014.11.009. Epub 2014 Dec 19.

PMID:
25532471
4.

Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer.

Feng TS, Sharif-Afshar AR, Smith SC, Miller J, Nguyen C, Li Q, Luthringer D, Li D, Saouaf R, Kim HL.

Urol Oncol. 2015 Mar;33(3):109.e15-22. doi: 10.1016/j.urolonc.2014.11.007. Epub 2014 Dec 12.

PMID:
25512160
5.

Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.

Li P, Conley A, Zhang H, Kim HL.

BMC Genomics. 2014 Dec 11;15:1087. doi: 10.1186/1471-2164-15-1087.

6.

Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis.

Shi C, Wu JB, Chu GC, Li Q, Wang R, Zhang C, Zhang Y, Kim HL, Wang J, Zhau HE, Pan D, Chung LW.

Oncotarget. 2014 Oct 30;5(20):10114-26.

7.

Learning curves for robot-assisted and laparoscopic partial nephrectomy.

Hanzly M, Frederick A, Creighton T, Atwood K, Mehedint D, Kauffman EC, Kim HL, Schwaab T.

J Endourol. 2015 Mar;29(3):297-303. doi: 10.1089/end.2014.0303. Epub 2014 Oct 21.

PMID:
25111313
8.
9.

The potential role for neoadjuvant therapy in renal cell carcinoma.

Ho D, Kim HL.

Clin Adv Hematol Oncol. 2013 Dec;11(12):777-82. Review.

PMID:
24893281
10.

Foxp3+ T cells inhibit antitumor immune memory modulated by mTOR inhibition.

Wang Y, Sparwasser T, Figlin R, Kim HL.

Cancer Res. 2014 Apr 15;74(8):2217-28. doi: 10.1158/0008-5472.CAN-13-2928. Epub 2014 Feb 26.

11.

Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.

Shao C, Liao CP, Hu P, Chu CY, Zhang L, Bui MH, Ng CS, Josephson DY, Knudsen B, Tighiouart M, Kim HL, Zhau HE, Chung LW, Wang R, Posadas EM.

PLoS One. 2014 Feb 14;9(2):e88967. doi: 10.1371/journal.pone.0088967. eCollection 2014.

12.

Gender disparity in kidney cancer treatment: women are more likely to undergo radical excision of a localized renal mass.

O'Malley RL, Underwood W 3rd, Brewer KA, Hayn MH, Kim HL, Mehedint DC, Safwat MW, Huang WC, Schwaab T.

Urology. 2013 Nov;82(5):1065-9.

PMID:
24358483
13.

Initial experience with arterial spin-labeling MR imaging to assess histology of renal masses.

Masarapu V, Kim HL.

Quant Imaging Med Surg. 2013 Jun;3(3):130-1. doi: 10.3978/j.issn.2223-4292.2013.06.05.

14.

Evaluation of a high-throughput, microfluidics platform for performing TaqMan™ qPCR using formalin-fixed paraffin-embedded tumors.

Li P, Grigorenko E, Funari V, Enright E, Zhang H, Kim HL.

Bioanalysis. 2013 Jul;5(13):1623-33. doi: 10.4155/bio.13.125.

15.

A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.

Zhang H, Berel D, Wang Y, Li P, Bhowmick NA, Figlin RA, Kim HL.

PLoS One. 2013;8(1):e54918. doi: 10.1371/journal.pone.0054918. Epub 2013 Jan 22.

16.

Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes.

Yang X, Shao C, Wang R, Chu CY, Hu P, Master V, Osunkoya AO, Kim HL, Zhau HE, Chung LW.

J Urol. 2013 Feb;189(2):702-10. doi: 10.1016/j.juro.2012.09.056. Epub 2012 Sep 20.

17.

Safety and outcomes of surgical treatment of renal cell carcinoma in the elderly.

O'Malley RL, Hayn MH, Hellenthal NJ, Kim HL, Underwood W 3rd, Schwaab T.

Can J Urol. 2012 Feb;19(1):6111-7.

PMID:
22316513
18.

Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible?

O'Malley RL, Brewer KA, Hayn MH, Kim HL, Underwood W 3rd, Pili R, Schwaab T.

Urology. 2011 Sep;78(3):595-600. doi: 10.1016/j.urology.2011.03.009. Epub 2011 Jul 20.

PMID:
21777963
19.

Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular cancer.

Underwood W, Kim HL.

BJU Int. 2012 Jan;109(2):281-5. doi: 10.1111/j.1464-410X.2011.10290.x. Epub 2011 Jun 1.

PMID:
21631699
20.

Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6.

Yu X, Yi H, Guo C, Zuo D, Wang Y, Kim HL, Subjeck JR, Wang XY.

J Biol Chem. 2011 May 27;286(21):18795-806. doi: 10.1074/jbc.M111.224345. Epub 2011 Apr 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk